CardieX Limited (AU:CDX) has released an update.
CardieX Limited reported positive outcomes from its 2024 Annual General Meeting, with all resolutions carried successfully. Key decisions included the re-election of directors and approvals for stock issuance and placement capacity, reflecting confidence in the company’s strategic direction. These developments highlight CardieX’s commitment to advancing its medical technology in vascular health.
For further insights into AU:CDX stock, check out TipRanks’ Stock Analysis page.